Jean-François Timsit (Marlieke E A de Kraker, Marlieke Ea de Kraker, Marlieke E A De Kraker)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Venues

The Journal of antimicrobial chemotherapy

PLoS medicine

JAC-antimicrobial resistance

Intensive care medicine

Geneva University Hospitals and Faculty of Medicine

Radboud Universiteit (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Geneva University Hospitals and Faculty of Medicine Mar 01 2015

Switzerland

Epidemiologist :: Infection Control Program

Education History

Radboud Universiteit Sep 01 1999 - Jul 31 2004

Netherlands

MSC :: Health Sciences

Publications

Hongyu Zhou, Niccolò Buetti, Salvador Pérez-Galera, Jose Bravo-Ferrer, Belén Gutiérrez Gutiérrez, María Paniagua-García, Jan Feifel, Julien Sauser, Tomi Kostyanev, Rafael Cantón, Lionel K Tan, Dimitris Basoulis, Vicente Pintado, Emmanuel Roilides, Gorana Dragovac, Julian Torre-Cisneros, Deana Mediç, Murat Akova, Herman Goossens, Marc Bonten, Stephan Harbarth, Jesús Rodríguez-Baño, Jean-François Timsit, null null
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Hongyu Zhou, Niccolò Buetti, Salvador Pérez-Galera, Jose Bravo-Ferrer, Belén Gutiérrez Gutiérrez, María Paniagua-García, Jan Feifel, Julien Sauser, Tomi Kostyanev, Rafael Cantón, Lionel K Tan, Dimitris Basoulis, Vicente Pintado, Emmanuel Roilides, Gorana Dragovac, Julian Torre-Cisneros, Deana Mediç, Murat Akova, Herman Goossens, Marc Bonten, Stephan Harbarth, Jesús Rodríguez-Baño, Jean-François Timsit, null null
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study. The Journal of antimicrobial chemotherapy (2024)
Ana Catalina Hernandez Padilla, Sylvain Meyer, Cornelis H Van Werkhoven, Jean-François Timsit, Bruno Francois
Are monoclonals the way forward to prevent or to treat ventilator-associated pneumonia in the intensive care unit? Expert opinion on biological therapy (2023)
Maria J G T Vehreschild, Lena M Biehl, Aaron Dane, Jean-François Timsit, Leen Timbermont, C Henri van Werkhoven
An obituary on DAV-132-authors' viewpoint on the current limits of pivotal trials in clinical microbiome research. The Journal of antimicrobial chemotherapy (2023)
Jean-François Timsit
Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries. PLoS medicine 20 (7) (2023)
Angela Dramowski, Gerald Ong'ayo, Andrea Mary Rehman, Andrew Whitelaw, Appiah-Korang Labi, Noah Obeng-Nkrumah, Awa Ndir, Marcelyn T Magwenzi, Kenneth Onyedibe, Martin Wolkewitz, Jean-François Timsit, J Anthony G Scott, Alexander M Aiken, null null
Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study. JAC-antimicrobial resistance 3 (1) (2021)
Angela Dramowski, Gerald Ong'ayo, Andrea Mary Rehman, Andrew Whitelaw, Appiah-Korang Labi, Noah Obeng-Nkrumah, Awa Ndir, Marcelyn T Magwenzi, Kenneth Onyedibe, Martin Wolkewitz, Jean-François Timsit, J Anthony G Scott, Alexander M Aiken
Erratum to: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study. JAC-antimicrobial resistance 3 (1) (2021)
Sara Tomczyk, Angelina Taylor, Allison Brown, Jean-François Timsit, Aiman El-Saed, Majid Alshamrani, Rene S Hendriksen, Megan Jacob, Sonja Löfmark, Olga Perovic, Nandini Shetty, Dawn Sievert, Rachel Smith, John Stelling, Siddhartha Thakur, Ann Christin Vietor, Tim Eckmanns, null null
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. The Journal of antimicrobial chemotherapy 76 (11) (2021)
Jean-François Timsit, Marlieke E A de Kraker, Harriet Sommer, Emmanuel Weiss, Esther Bettiol, Martin Wolkewitz, Stavros Nikolakopoulos, David Wilson, Stephan Harbarth, null null
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net. Intensive care medicine 43 (7) (2017)
Jean-François Timsit, Andrew J Stewardson, Stephan Harbarth
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? PLoS medicine 13 (11) (2016)

Jean-François Timsit.css-eqlu8i{font-size:small;padding-left:4px;} (Marlieke E A de Kraker, Marlieke Ea de Kraker, Marlieke E A De Kraker)

Publication Activity (10 Years)

Top Topics

Top Venues

Jean-François Timsit (Marlieke E A de Kraker, Marlieke Ea de Kraker, Marlieke E A De Kraker)